Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Intensive care units with low versus high volume of myocardial infarction: clinical outcomes, resource utilization, and quality metrics.

Stolker JM, Badawi O, Spertus JA, Nasir A, Kennedy KF, Harris IH, Franey CS, Hsu VD, Ripple GR, Howell GH, Lem VM, Chan PS.

J Am Heart Assoc. 2015 Jun 11;4(6):e001225. doi: 10.1161/JAHA.114.001225.

2.

Prescription fill patterns in underserved children with asthma receiving subspecialty care.

Bollinger ME, Mudd KE, Boldt A, Hsu VD, Tsoukleris MG, Butz AM.

Ann Allergy Asthma Immunol. 2013 Sep;111(3):185-9. doi: 10.1016/j.anai.2013.06.009. Epub 2013 Jul 21.

3.

Influence of creatinine versus glomerular filtration rate on non-steroidal anti-inflammatory drug prescriptions in chronic kidney disease.

Patel K, Diamantidis C, Zhan M, Hsu VD, Walker LD, Gardner J, Weir MR, Fink JC.

Am J Nephrol. 2012;36(1):19-26. doi: 10.1159/000339439. Epub 2012 Jun 13.

4.

A varying patient safety profile between black and nonblack adults with decreased estimated GFR.

Diamantidis CJ, Seliger SL, Zhan M, Walker L, Rattinger GB, Hsu VD, Fink JC.

Am J Kidney Dis. 2012 Jul;60(1):47-53. doi: 10.1053/j.ajkd.2012.01.023. Epub 2012 Apr 6.

PMID:
22483674
5.

Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data.

Hanna NN, Onukwugha E, Choti MA, Davidoff AJ, Zuckerman IH, Hsu VD, Mullins CD.

Colorectal Dis. 2012 Jan;14(1):48-55. doi: 10.1111/j.1463-1318.2011.02545.x.

PMID:
21689262
6.

Effect of urologists and medical oncologists on treatment of elderly men with Stage IV prostate cancer.

Onukwugha E, Mullins CD, Hsu VD, Seal B, Hussain A.

Urology. 2011 May;77(5):1088-95. doi: 10.1016/j.urology.2010.11.059. Epub 2011 Mar 25.

PMID:
21439617
7.

Erythropoiesis-stimulating agents increase the risk of acute stroke in patients with chronic kidney disease.

Seliger SL, Zhang AD, Weir MR, Walker L, Hsu VD, Parsa A, Diamantidis CJ, Fink JC.

Kidney Int. 2011 Aug;80(3):288-94. doi: 10.1038/ki.2011.49. Epub 2011 Mar 9.

8.

Sensitivity of nursing home cost comparisons to method of dementia diagnosis ascertainment.

Gruber-Baldini AL, Stuart B, Zuckerman IH, Hsu VD, Boockvar KS, Zimmerman S, Kittner S, Quinn CC, Hebel JR, May C, Magaziner J.

Int J Alzheimers Dis. 2009 Sep 22;2009:780720. doi: 10.4061/2009/780720.

9.

Timing of erythropoiesis-stimulating agent initiation and adverse outcomes in nondialysis CKD: a propensity-matched observational study.

Seliger S, Fox KM, Gandra SR, Bradbury B, Hsu VD, Walker L, Chiou CF, Fink JC.

Clin J Am Soc Nephrol. 2010 May;5(5):882-8. doi: 10.2215/CJN.07171009. Epub 2010 Mar 18.

10.

Adverse safety events in chronic kidney disease: the frequency of "multiple hits".

Chapin E, Zhan M, Hsu VD, Seliger SL, Walker LD, Fink JC.

Clin J Am Soc Nephrol. 2010 Jan;5(1):95-101. doi: 10.2215/CJN.06210909. Epub 2009 Dec 3.

11.

Adherence feedback to improve asthma outcomes among inner-city children: a randomized trial.

Otsuki M, Eakin MN, Rand CS, Butz AM, Hsu VD, Zuckerman IH, Ogborn J, Bilderback A, Riekert KA.

Pediatrics. 2009 Dec;124(6):1513-21. doi: 10.1542/peds.2008-2961.

12.

The frequency of hyperkalemia and its significance in chronic kidney disease.

Einhorn LM, Zhan M, Hsu VD, Walker LD, Moen MF, Seliger SL, Weir MR, Fink JC.

Arch Intern Med. 2009 Jun 22;169(12):1156-62. doi: 10.1001/archinternmed.2009.132.

13.

Frequency of hypoglycemia and its significance in chronic kidney disease.

Moen MF, Zhan M, Hsu VD, Walker LD, Einhorn LM, Seliger SL, Fink JC.

Clin J Am Soc Nephrol. 2009 Jun;4(6):1121-7. doi: 10.2215/CJN.00800209. Epub 2009 May 7.

14.

CKD as an underrecognized threat to patient safety.

Fink JC, Brown J, Hsu VD, Seliger SL, Walker L, Zhan M.

Am J Kidney Dis. 2009 Apr;53(4):681-8. doi: 10.1053/j.ajkd.2008.12.016. Epub 2009 Feb 26. Review.

15.

Seasonal patterns of controller and rescue medication dispensed in underserved children with asthma.

Butz AM, Thompson RE, Tsoukleris MG, Donithan M, Hsu VD, Mudd K, Zuckerman IH, Bollinger ME.

J Asthma. 2008 Nov;45(9):800-6. doi: 10.1080/02770900802290697.

16.

Chronic kidney disease adversely influences patient safety.

Seliger SL, Zhan M, Hsu VD, Walker LD, Fink JC.

J Am Soc Nephrol. 2008 Dec;19(12):2414-9. doi: 10.1681/ASN.2008010022. Epub 2008 Sep 5.

17.

Validation of a method for identifying nursing home admissions using administrative claims.

Zuckerman IH, Sato M, Hsu VD, Hernandez JJ.

BMC Health Serv Res. 2007 Dec 10;7:202.

18.

The relationship between dialysis performance measures: adequacy and anemia management.

Spolter YS, Seliger SL, Zhan M, Hsu VD, Walker LD, Fink JC.

Am J Kidney Dis. 2007 Nov;50(5):774-81.

PMID:
17954290
19.

Concordance of Medicaid and pharmacy record data in inner-city children with asthma.

Mudd KE, Bollinger ME, Hsu VD, Manning A, Tsoukleris MG, Butz AM.

Contemp Clin Trials. 2008 Jan;29(1):13-20. Epub 2007 May 21.

PMID:
17574930
20.

Center effects in anemia management of dialysis patients.

Fink JC, Hsu VD, Zhan M, Walker LD, Mullins CD, Jones-Burton C, Langenberg P, Seliger SL.

J Am Soc Nephrol. 2007 Feb;18(2):646-53. Epub 2007 Jan 17.

21.

Patterns of inhaled antiinflammatory medication use in young underserved children with asthma.

Butz AM, Tsoukleris M, Donithan M, Hsu VD, Mudd K, Zuckerman IH, Bollinger ME.

Pediatrics. 2006 Dec;118(6):2504-13.

22.

Pharmacy fill patterns in young urban children with persistent asthma.

Mudd K, Bollinger ME, Hsu VD, Donithan M, Butz A.

J Asthma. 2006 Oct;43(8):597-600.

PMID:
17050224
23.

Effectiveness of nebulizer use-targeted asthma education on underserved children with asthma.

Butz AM, Tsoukleris MG, Donithan M, Hsu VD, Zuckerman I, Mudd KE, Thompson RE, Rand C, Bollinger ME.

Arch Pediatr Adolesc Med. 2006 Jun;160(6):622-8.

24.

National estimates of exposure to prescription drugs with addiction potential in community-dwelling elders.

Simoni-Wastila L, Zuckerman IH, Singhal PK, Briesacher B, Hsu VD.

Subst Abus. 2005 Mar;26(1):33-42.

PMID:
16492661
25.

Racial variations in erythropoietic response to epoetin alfa in chronic kidney disease and the impact of smoking.

Jones-Burton C, Seliger SL, Brown J, Stackiewicz L, Hsu VD, Fink JC.

Nephrol Dial Transplant. 2005 Dec;20(12):2739-45. Epub 2005 Sep 27.

PMID:
16188897
26.

Variability and growth in spending for outpatient specialty pharmaceuticals.

Mullins CD, DeVries AR, Hsu VD, Meng F, Palumbo FB.

Health Aff (Millwood). 2005 Jul-Aug;24(4):1117-27.

PMID:
16012152
27.

Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance: findings from the state of Ohio medicaid program.

Cluxton RJ Jr, Li Z, Heaton PC, Weiss SR, Zuckerman IH, Moomaw CJ, Hsu VD, Rodriguez EM.

Pharmacoepidemiol Drug Saf. 2005 Jan;14(1):1-9.

PMID:
15546159
28.

Clinical correlates of estrogen replacement therapy use and duration of use among medicaid recipients.

Weiss SR, Zuckerman IH, Huang X, Hsu VD.

J Womens Health Gend Based Med. 2001 Oct;10(8):811-9.

PMID:
11703894
29.

Criteria for use of ticlopidine in adult inpatients and outpatients.

Hsu VD.

Clin Pharm. 1993 Jan;12(1):64-6. No abstract available.

PMID:
8428436
30.

Criteria for use of sumatriptan in adult inpatients and outpatients.

Hsu VD.

Clin Pharm. 1992 Nov;11(11):972-4. No abstract available.

PMID:
1334453
31.

Sumatriptan: a new drug for vascular headache.

Hsu VD.

Clin Pharm. 1992 Nov;11(11):919-29. Review.

PMID:
1334452

Supplemental Content

Support Center